Frontiers in Immunology (Jul 2023)

In vitro differentiated human CD4+ T cells produce hepatocyte growth factor

  • Shayne Lavondua Ford,
  • Terkild Brink Buus,
  • Claudia Nastasi,
  • Carsten Geisler,
  • Charlotte Menné Bonefeld,
  • Niels Ødum,
  • Anders Woetmann

DOI
https://doi.org/10.3389/fimmu.2023.1210836
Journal volume & issue
Vol. 14

Abstract

Read online

Differentiation of naive CD4+ T cells into effector T cells is a dynamic process in which the cells are polarized into T helper (Th) subsets. The subsets largely consist of four fundamental categories: Th1, Th2, Th17, and regulatory T cells. We show that human memory CD4+ T cells can produce hepatocyte growth factor (HGF), a pleiotropic cytokine which can affect several tissue types through signaling by its receptor, c-Met. In vitro differentiation of T cells into Th-like subsets revealed that HGF producing T cells increase under Th1 conditions. Enrichment of HGF producing cells was possible by targeting cells with surface CD30 expression, a marker discovered through single-cell RNA-sequencing. Furthermore, pharmacological inhibition of PI3K or mTOR was found to inhibit HGF mRNA and protein, while an Akt inhibitor was found to increase these levels. The findings suggest that HGF producing T cells could play a role in disease where Th1 are present.

Keywords